See here for insights on Carl Icahn’s Q3 2025 portfolio updates: new stocks added, key stake changes, and dividend cuts.

In May, Hindenburg Research alleged that Icahn’s investment vehicle, IEP, had inflated asset values. The report also revealed that Icahn had borrowed from his own company. Icahn attributed the second ...

Love him or hate him, investor Carl Icahn may be in control of Dell by Thursday if Dell CEO Michael Dell is unsuccessful with his $24.4 billion leveraged buyout plan. Icahn has been both vilified and ...

The name Carl Icahn still has material cachet on Wall Street, though some of his most public investment battles happened decades ago. Icahn Enterprises (NASDAQ: IEP) is Carl Icahn's publicly traded ...

Explore how Gates, Soros, Icahn, Rockefeller, and Morgan redefined Wall Street with innovation, strategy, and bold tactics in ...

Carl Icahn is one of the most famous investors in history. Throughout the 1980s and 1990s, he became known as a corporate raider, buying up big stakes in companies in an attempt to force change. Over ...

The activist is facing trouble at home and in the office, but he’s making new investments and is looking to swing at Larry Fink. Any bump in a targeted company’s stock price evaporates within a year, ...

Carl Icahn's 13F portfolio remained steady with 14 holdings, including top positions in Icahn Enterprises, CVR Energy, Southwest Gas, International Flavors & Fragrances, and CVR Partners LP. New ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Role was previously held by the ...

Icahn Enterprises is a complex company that is hard to define, but the best comparison would probably be private equity. Icahn Enterprises isn't trying to hide anything. It's very clear in the company ...

Shares have lost more than 60% of their value over the past year, potentially creating a buying opportunity. Perhaps there will come a time to buy, but the current valuation should scare off prudent ...